Hepatitis B immunisation for adults with end-stage kidney disease

Author:

Borges do Nascimento Israel Junior12,Pac Agnieszka3,Zanghelini Fernando4,Civile Vinicius T5,Correa Nadine E6,Abdulazeem Hebatullah M7

Affiliation:

1. School of Medicine and University Hospital; Universidade Federal de Minas Gerais (UFMG); Belo Horizonte Brazil

2. Data and Digital Health (DDH) at Division of Country Health Policies and Systems (CPS); World Health Organization - Regional Office for Europe; Copenhagen  Denmark

3. Chair of Epidemiology and Preventive Medicine, Department of Epidemiology; Jagiellonian University Medical College; Krakow Poland

4. Newcastle University; Newcastle upon Tyne UK

5. Evidence-Based Health Post-Graduation Program, Universidade Federal de São Paulo; Cochrane Brazil; Department of Physiotherapy, Universidade Paulista; Sao Paulo Brazil

6. Health Sciences Department; Federal University of Santa Catarina; Araranguá Brazil

7. Institute for Medical Information Processing; Biometry, and Epidemiology, Pettenkofer School of Public Health LMU Munich; Munich Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference100 articles.

1. The extrahepatic manifestations of hepatitis B virus;Baig;Journal of the College of Physicians and Surgeons Pakistan,2008

2. Recommendations for preventing transmission of infections among chronic hemodialysis patients;Centers for Disease Control and Prevention;MMWR - Recommendations and Reports : Morbidity and Mortality Weekly Report,2001

3. Centers for Disease Control and Prevention A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States/recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults MMWR  - Department of Health and Human Services Centers for Disease Control and Prevention 2006 55 RR-16 1 33

4. Centers for Disease Control and Prevention Chronic kidney disease basics www.cdc.gov/kidneydisease/basics.html

5. Centers for Disease Control and Prevention Hepatitis B questions and answers for health professionals www.cdc.gov/hepatitis/hbv/hbvfaq.htm

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3